| Date Filed | Type | Description |
| 08/09/2023 |
4
| MAZANET ROSEMARY (Chief Scientific Officer) has filed a Form 4 on Columbia Care Inc.|
Txns:
| Granted 909,091 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| MAZANET ROSEMARY (Chief Scientific Officer) has filed a Form 4 on Columbia Care Inc.|
Txns:
| Paid exercise price by delivering 4,441 shares
@ $0.48, valued at
$2.1k
Exercised 19,032 restricted stock units
@ $0 |
|
| 06/30/2023 |
4
| MAZANET ROSEMARY (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $0.3553, valued at
$8.9k
|
|
| 05/05/2023 |
4
| MAZANET ROSEMARY (Chief Scientific Officer) has filed a Form 4 on Columbia Care Inc.|
Txns:
| Paid exercise price by delivering 42,911 shares
@ $0.49, valued at
$21k
Exercised 54,775 restricted stock units
@ $0
Exercised 18,171 restricted stock units
@ $0
Exercised 37,790 restricted stock units
@ $0 |
|
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| MAZANET ROSEMARY (Chief Scientific Officer) has filed a Form 4 on Columbia Care Inc.|
Txns:
| Paid exercise price by delivering 15,479 shares
@ $0.74, valued at
$11.5k
Exercised 43,535 restricted stock units
@ $0 |
|
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| MAZANET ROSEMARY (Chief Scientific Officer) has filed a Form 4 on Columbia Care Inc.|
Txns:
| Paid exercise price by delivering 53,599 shares
@ $2.75, valued at
$147.4k
Exercised 18,171 restricted stock units
@ $0
Exercised 42,024 restricted stock units
@ $0
Exercised 54,776 restricted stock units
@ $0
Exercised 19,032 restricted stock units
@ $0 |
|
| 04/14/2022 |
4
| MAZANET ROSEMARY (Chief Scientific Officer) has filed a Form 4 on Columbia Care Inc.|
Txns:
| Granted 151,163 restricted stock units
@ $0
Granted 166,113 restricted stock units
@ $0 |
|
| 02/14/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/27/2021 |
4
| MAZANET ROSEMARY (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $5.14, valued at
$128.5k
|
|
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/02/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/19/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/17/2012 |
3
| Form 3 - Initial statement of beneficial ownership of securities |